🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

7+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 7 of 7 recruiting trials for “malignant-mixed-mullerian-tumor-of-the-ovary”

Phase 1RecruitingNCT07029399 ↗

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

🏥 NiKang Therapeutics, Inc.📍 14 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06268665 ↗

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

👨‍⚕️ Eve Rodler, MD, University of California, Davis📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT05937620 ↗

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

👨‍⚕️ Berta Diaz-Feijoo, Physician, Hospital Clinic of Barcelona📍 1 site📅 Started Sep 2023View details ↗
NARecruitingNCT06061874 ↗

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis

👨‍⚕️ Patrick Flamen, Jules Bordet Institute📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05619913 ↗

EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

👨‍⚕️ Clare Scott, AM MB BS PhD, Peter MacCallum Cancer Centre, Australia📍 6 sites📅 Started May 2023View details ↗
NARecruitingNCT05457595 ↗

Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

👨‍⚕️ Amelia Barcellini, MD, CNAO National Center of Oncological Hadrontherapy📍 1 site📅 Started Feb 2021View details ↗
Phase 1, PHASE2RecruitingNCT03686124 ↗

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

👨‍⚕️ Cedrik Britten, M.D., Immatics US, Inc.📍 19 sites📅 Started May 2019View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →